The Role of Genetic Factors in the Development of Myocardial Infarction in the Kazakh Population

NCT05090618 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-03-14

No results posted yet for this study

Summary

This is a GWAS study that aims to identify possible candidate genes associate to heart attack by exploring single nucleotide polymorphism (SNP) in a group of heart attack, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with heart attack

Conditions

Interventions

GENETIC

DNA analysis

GWAS

Sponsors & Collaborators

  • Asfendiyarov Kazakh National Medical University

    lead OTHER

Principal Investigators

  • Aisulu Mussagaliyeva, PhD · Research Institute of Cardiology and Internal Medicine

  • Roza Kuanyshbekova · Research Institute of Cardiology and Internal Medicine

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-23
Primary Completion
2023-01-20
Completion
2023-01-20

Countries

  • Kazakhstan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05090618 on ClinicalTrials.gov